Northwest Biotherapeutics Inc (NWBO) income statement
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- –
- Operating margin
- -2316.1%
- Net margin
- -1736.4%
- Return on equity, FY2025
- 77.7%
Financial strength
- Current ratio
- 0.04
- Debt to equity
- -0.27
- Debt to assets
- 16.1%
- Cash to current liabilities
- 0.8%
Valuation
- P/E ratio
- –
- Price to sales
- 117.25
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?